genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
One COVID-19 Shot, Two Approaches
Bioprocessing
Waters Opens Cambridge, MA, Collaboration Lab
Gene Therapy
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
Coronavirus
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Bioprocessing
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
News
Antibodies
In Race to Supply Smallest Antibodies, Cows Outpace Camelids
Coronavirus
FDA Places Partial Clinical Hold on INOVIO Trial of COVID-19 Vaccine
Coronavirus
BARDA Balks at “Warp Speed” Funding for Oragenics COVID-19 Vaccine
Cancer
Researchers Keep Cancer Cells Out by Blocking the Gate to the…
Alzheimers
Alzheimer’s Epigenetic Drivers Identified
Insights
All
Trends for 2020
Bioprocessing
Continuous Bioprocessing and 4.0 Tech Key to Bypassing Bottlenecks
Bioprocessing
Cytiva Tests Filtration for Lentivirus Production
Bioprocessing
Observing the Performance of Planova Filters
Bioprocessing
Novel Tech Approaches for Analyzing Aggregation
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Antibodies
In Race to Supply Smallest Antibodies, Cows Outpace Camelids
eBooks
The Future of Drug Discovery
Bioprocessing
Continuous Bioprocessing and 4.0 Tech Key to Bypassing Bottlenecks
Bioprocessing
Cytiva Tests Filtration for Lentivirus Production
Magazine
All
Supplement
September 2020 Vol. 40 No. 9
Cold Cases Heat Up with New Forensic DNA Methods
September 2020 Vol. 40 No. 9
CRISPR Value Chains Support New Therapeutic Strategies
September 2020 Vol. 40 No. 9
Nonviral CRISPR Delivery Vehicles Lay the Smart Siege
Point of View
Multimodal Screening—The Future of Drug Discovery and Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
RNA
mRNA
mRNA
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
mRNA
Regulatory RNA Control with Light
mRNA
COVID-19: AstraZeneca, U. of Oxford Resume Phase III Trial; Pfizer, BioNTech Eye 14,000 More Participants
mRNA
Novel Diabetes Therapy Might Be Found in Protein Commonly Found Throughout the Body
mRNA
Moderna COVID-19 Vaccine Shows Immunogenicity in Older Patients
mRNA
U.S. Raises to $2.5B toward Its “Warp Speed” Bet on Moderna’s COVID-19 Vaccine
mRNA
Pfizer, BioNTech Begin Phase II/III Trial of COVID-19 Vaccine, Switching Lead...
mRNA
Moderna Launches 30,000-Patient Phase III Trial of COVID-19 Vaccine
mRNA
Moderna Eyes Appeal as Board Upholds an Arbutus Lipid Nanoparticle Patent
mRNA
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
mRNA
Moderna Advancing COVID-19 Vaccine into Phase III after Positive Initial Clinical...
mRNA
Pfizer, BioNTech Publish “Encouraging” Interim Phase I/II Data for COVID-19 Vaccine...
mRNA
Brain Cell Study Opens Door to New Therapies for Epilepsy
mRNA
Sanofi Adds COVID-19, Flu Candidates to up to $2.3B+ mRNA Vaccine...
mRNA
BIA Separations Introduces PrimaS Multi-Mode Ligand Bioprocess Technology
mRNA
Moderna Reports Positive Interim Phase I Results for COVID-19 Vaccine
Load more
Scroll Up
Please share your location to continue
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
